Deletion, but not anergy, is involved in TGF-β-treated antigen-presenting cell-induced tolerance

International Immunology

Volumn 15, Issue 8, 2003, Pages 945-953

  Alard, Pascale ^a   Clark, Sherry L ^a   Kosiewicz, Michele M ^a  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

Anergy; Fas ligand; T cell; Tolerance; Transforming growth factor

Indexed keywords

ADJUVANT; ANTIGEN; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 2; PROTEIN ANTIBODY; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CELL DEATH; CLONAL ANERGY; CONTROLLED STUDY; CORRELATION ANALYSIS; DELAYED HYPERSENSITIVITY; EFFECTOR CELL; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INJECTION; LYMPHOCYTE COUNT; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL DEATH; CELL DIVISION; CELLS, CULTURED; CLONAL ANERGY; CLONAL DELETION; FAS LIGAND PROTEIN; FEMALE; FLOW CYTOMETRY; FLUORESCEINS; IMMUNE TOLERANCE; INTERLEUKIN-2; LYMPH NODES; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; OVALBUMIN; PEPTIDE FRAGMENTS; PERITONEAL CAVITY; RECEPTORS, ANTIGEN, T-CELL; SUCCINIMIDES; THIOGLYCOLATES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0041522510     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/mcg092     Document Type: Article

References (30)

1. Wilbanks, G. A., Mammolenti, M. and Streilein, J. W. 1992. Studies on the induction of anterior chamber-associated immune deviation (ACAID), III. Induction of ACAID depends upon intraocular transforming growth factor-beta. Eur. J. Immunol. 22:165.
2. Hara, Y., Okamoto, S., Rouse, B. and Streilein, J. W. 1993. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type. J. Immunol. 151:5162.
3. Kosiewicz, M. M., Okamoto, S., Miki, S., Ksander, B. R., Shimizu, T. and Streilein, J. W. 1994. Imposing deviant immunity on the presensitized state. J. Immunol. 153:2962.
4. Kosiewicz, M. M. and Streilein, J. W. 1996. Intraocular injection of class II-restricted peptice induces an unexpected population of CD8 regulatory cells. J. Immunol. 157:1905.
5. Hara, Y., Caspi, R. R., Wiggert, B., Dorf, M. and Streilein, J. W. 1992. Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye. J. Immunol. 149:1531.
6. Okamoto, S., Kosiewicz, M. M., Caspi, R. R. and Streilein, J. W. 1994. ACAID as a potential therapy of established experimental autoimmune uveitis. In Nussenblatt, S. M., Caspi, R. R. and Gery, I., eds, Proceedings of the 6th International Symposium on the Immunology and Immunopathology of the Eye, p. 195. Elsevier Science, Bethesda, MD.
7. Schwartz, R. H., Mueller, D. L., Jenkins, M. K. and Quill, H. 1989. T-cell clonal anergy. Cold Spring Harbor Symp. Quant. Biol. 54:605.
8. Schwartz, R. H. 1996. Models of T cell anergy: is there a common molecular mechanism? [Comment]. J. Exp. Med. 184:1.
9. Greenwald, R. J., Boussiotis, V. A., Lorsbach, R. B., Abbas, A. K. and Sharpe, A. H. 2001. CTLA-4 regulates induction of anergy in vivo. Immunity 14:145.
10. von Herrath, M. G., Dyrberg, T. and Oldstone, M. B. A. 1996. Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. J. Clin. Invest. 98:1324.
11. Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L. and Powrie, F. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190:995.
12. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737.
13. Roncarolo, M. G., Bacchetta, R., Bordignon, C., Narula, S. and Levings, M. K. 2001. Type 1 T regulatory cells. Immunol. Rev. 182:68.
14. + T cells. J. Exp. Med. 183:2669.
15. - thymocytes. J. Exp. Med. 189:279.
16. Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A. and Weiner, H. L. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237.
17. Miller, A., Lider, O., Roberts, A. B., Sporn, M. B. and Weiner, H. L. 1992. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc. Natl Acad. Sci. USA 89:421.
18. Chen, Y., Inobe, J., Marks, R., Gonnella, P., Kuchroo, V. K. and Weiner, H. L. 1995, Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:177.
19. Lynch, D. H., Ramsdell, F. and Alderson, M. R. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16:569.
20. Martin, D. A., Zheng, L., Siegel, R. M., Huang, B., Fisher, G. H., Wang, Jackson, C. E., Puck, J. M., Dale, J., Strauss, S. E., Peter, M. E., Krammer, P. H., Fesik, S. and Lenardo, M. J. 1999. Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. Proc. Natl Acad. Sci. USA 96:4552.
21. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T. and Nagata, S. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
22. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N, G., Jenkins, N. A. and Nagata, S. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
23. Egan, R. M., Yorkey, C., Black, R., Loh, W. K., Stevens, J. L., Storozynsky, E., Lord, E. M., Frelinger, J. G. and Woodward, J. G. 2000. In vivo behavior of peptide-specific T cells during mucosal tolerance induction: antigen introduced through the mucosa of the conjunctiva elicits prolonged antigen-specific T cell priming followed by anergy. J. Immunol. 164:4543.
24. Sakaguchi, S., Salkaguchi, N., Asano, M., Itoh, M. and Toda, M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151.
25. Weiner, H. L. 1997. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today 18:335.
26. Chen, Z. K., Cobbold, S. P., Waldman, H. and Metcalfe, S. 1996. Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation 62:1200.
27. Kearney, E. R., Pape, K. A., Loh, D. Y. and Jenkins, M. K. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327.
28. Takeuchi, M., Kosiewicz, M. M., Alard, P. and Streilein, J. W. 1997. On the mechanisms by which transforming growth factor-β2 alters antigen-presenting abilities of macrophages on T cell activation. Eur. J. Immunol. 27:1648.
29. Takeuchi, M., Alard, P. and Streilein, J. W. 1998. TGF-β promotes immune deviation by altering accessory signals of antigen-presenting cells. J. Immunol. 160:1589.
30. Takeuchi, M., Alard, P., Verbik, D., Ksander, B. and Streilein, J. W. 1999. Anterior chamber-associated immune deviation-inducing cells activate T cells, and rescue from antigen-induced apoptosis. Immunology 98:576.